Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation Post author:Sam Post published:November 29, 2017 Post category:BioPharma Genmab just received a $20M milestone payment from Janssen Biotech. Source: BioSpace You Might Also Like 5 Top Biotech Stocks That Look Vulnerable in 2018 January 8, 2018 Amag Investors Cheer as Biotech Wins Second Drug Approval This Month February 15, 2018 Sources Reveal Tesaro is Unlikely to Find a Buyer July 13, 2017
